Clinical Trial Update: Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema [Phase 4]

View source ↗

Summary

Phase 4 trial update examining long-term effectiveness and safety of intravitreal bevacizumab for retinal neovascularization and macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Retinal Neovascularization

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Retinal Neovascularization, Macular Edema | Phase 4 | Status: UNKNOWN